Canadian Cannabis Producer Stocks Soar 27% in January – New Cannabis Ventures

Warning: sprintf(): Too few arguments in /home/prosofte/domains/ on line 319

The Canadian Cannabis LP Index started 2021 strongly, advancing 26.7% to 348.75:

The index, which rallied 22.1% in Q4 but still fell 30.1% in 2020, is down 8.6% over the past year :

It remains substantially below the all-time closing high of 1314.33 in September 2018, just ahead of Canadian legalization. In March, it posted a new 52-week closing low of 196.10, a level not seen since late 2016, and it closed 77.8% above that level at the end of January:

The Canadian Cannabis LP Index, which is rebalanced monthly, included 34 qualifying publicly traded licensed producers that traded in Canada at the end of December, with equal weighting for each stock. Each of the members was also included in a sub-index, with 4 in the Canadian Cannabis LP Tier 1 Index, 11 in the Canadian Cannabis LP Tier 2 Index and 19 in the Canadian Cannabis LP Tier 3 Index during the month. At the end of June, we revised the rules for inclusion, requiring companies to have a price of at least C$0.20 unless they are generating at least C$2.5 million quarterly from their cannabis production operation. Previously, we required revenue in excess of C$1 million for stocks trading below C$0.20. There are currently about two dozen publicly traded LPs that fail to qualify.

Tier 1

Tier 1, which included the LPs that are generating cannabis-related sales of at least C$25 million per quarter, soared 62% to 792.14, extending its gains since the U.S. elections in November. Tier 1 dropped 23.9% in 2020, ending the year at 488.96. We have increased the minimum revenue required to be included over time. At the beginning of 2021, we raised it from C$20 million. During 2019 and the first half of 2020, companies needed to generate revenue in excess of C$10 million for inclusion. In 2018, we used C$4 million as the hurdle.

This group included Aphria (TSX: APHA) (NASDAQ: APHA), Aurora Cannabis (TSX: ACB) (NYSE: ACB), Canopy Growth (TSX: WEED) (NASDAQ: CGC) and HEXO Corp (TSX: HEXO) (NYSE: HEXO).

Among these largest LPs by revenue, Aurora Cannabis was the worst performer, gaining 33.8%. Aphria performed the best, rising 76.7%.

Tier 2

Tier 2, which included the LPs that generate cannabis-related quarterly sales between C$5 million and C$25 million, rose 31.1% to 478.99. In 2020, it lost 35.9% in 2020, closing at 365.19. Prior to July 2020, companies needed revenue in excess of C$2.5 million to be included in this tier.

This group included Auxly (TSXV: XLY) (OTC: CBWTF), Cronos Group (TSX: CRON) (NASDAQ: CRON), Delta 9 (TSX: DN) (OTC: VNRDF), Organigram (TSX: OGI) (NASDAQ: OGI), Supreme Cannabis (TSX: FIRE) (OTC: SPRWF), TerrAscend (CSE: TER) (OTC: TRSSF), Valens Company (TSX: VLNS) (OTC: VLNCF), Village Farms (TSX: VFF) (NASDAQ: VFF), VIVO Cannabis (TSX: VIVO) (OTC: VVCIF), WeedMD (TSXV: WMD) (OTC: WDDMF) and Zenabis Global (TSX: ZENA) (OTC: ZBISF).

The worst performer was Delta 9, which declined almost 8%, while Zenabis, up 119%, was the best performer.

Tier 3

Tier 3, which included the 20 qualifying LPs that generate cannabis-related quarterly sales less than C$5 million, rose 16.8% as it closed at 77.76. It ended at 66.59 in 2020, declining 31.2%. The strongest performer was Decibel Cannabis (CSE: DBCCF), which was the best performing stock in the broader index as well.

The returns for the overall sector varied greatly, with 6 names gaining more than 50% and 3 declining by more than 10%. The entire group posted a median return of 22.6%:

For February, the overall index will have 36 constituents after the removal of Rapid Dose Therapeutics, which fell below the minimum price for companies generating less than C$2.5 million quarterly LP revenue, and the additions of Eve & Co, Namaste Technologies and Nextleaf Solutions.

In the next monthly review, we will summarize the performance for February and discuss any additions or deletions. Be sure to bookmark the pages to stay current on LP stock price movements within the day or from day-to-day.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter

Expect More Cannabis Mergers After Leading American Operators… – New Cannabis Ventures

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news.


2021 is off to a fantastic start for cannabis investors. We will be detailing the performance shortly, but the New Cannabis Ventures Global Cannabis Stock Index tacked on a 27.8% gain in January on top of the Q4 rise of nearly 62%. Since the end of September, the index has more than doubled.

Four weeks ago, we discussed why we expected the growth to continue, sharing 9 potential growth drivers, and some of these are already kicking in, especially on two fronts: improving access to capital and a heightened pace of M&A.

During January, seven of the largest American multi-state operators (MSOs) by market cap raised equity capital that we would consider for growth. The deals got done at relatively tight discounts to the market price, typically without warrants, and were supported by substantial institutional investor participation. Beyond the equity markets, Curaleaf priced a $50 million debt deal that suggests improving terms for borrowing.

The table below shows the amount of capital raised by each company:

Capital raising wasn’t limited to MSOs, as we saw several Canadian licensed producers (LPs) sell shares. These deals were less about growth capital than balance sheet repair for the most part, but some of the capital raises, like Village Farms, were for growth.

M&A has been taking place in both Canada and the U.S. We first shared our expectation that consolidation would be a big theme in mid-December, right before Ayr Strategies announced two single-state operator buys and Columbia Care announced the pending acquisition of private MSO Green Leaf Medical. Since then, Columbia Care announced another California acquisition, while Cresco Labs announced the pending acquisition of Florida operator Bluma Wellness. In Canada, Israeli operator IM Cannabis announced the pending acquisition of Trichome Financial, Heritage Cannabis bought a private LP, Valens announced it is acquiring a private LP, and Alcanna, as part of a spin-out of its retail cannabis operations, will be acquiring another retailer, YSS.

Another early theme has been very high trading volumes, especially for names that trade on higher exchanges. For the MSOs, we believe that the scaling up of AdvisorShares Pure US Cannabis ETF as well as increasing institutional demand has helped boost trading volumes, and these higher volumes have made it easier for companies to raise capital or insiders and early investors to sell stock without disrupting the price significantly.

Looking ahead, we expect that a lot of the M&A will likely be consolidation of private single-state operators or small MSOs, so it’s not clear that there are obvious public company acquisition targets in the U.S, but we think that we might see some consolidation in Canada that could include public company combinations. We believe that Curaleaf is a very likely consolidator, and we have shared that we expect it to make an acquisition in California

As we mentioned, seven of the largest MSOs have raised capital for growth, and the other three might do so as well. We note that after filing its initial S-1 to sell up to 10 million shares in August, GTI amended it on January 19th, perhaps a signal that it could be issuing equity. On Friday evening, Trulieve disclosed that it has filed a $750 million shelf registration. Harvest Health and Recreation also has an open shelf. Of course, smaller MSOs may raise equity capital as well. We continue to expect equity offerings in the U.S. to be well absorbed. This suggests that investors should be prepared to “buy the dip” on equity offerings, a strategy that can work due to the bull market that cannabis stocks are in now.

2021 began with a sharp spike in stocks in the first two weeks, triggered by the change of control of the Senate. While the back half of the month saw a modest pullback, the market looks very healthy from our vantage. With corporate coffers topped off after this recent round of capital raising, we expect the pace of M&A to accelerate in the months ahead.

Why Investors Subscribe:
Real-time, market moving news and analysis! Cut out the noise and get the facts straight from the longest running full-time cannabis analyst.

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:

To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.

Get ahead of the crowd! If you are a cannabis investor and find value in our Sunday newsletters, subscribe to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013. Gain immediate access to real-time and in-depth information and market intelligence about the publicly traded cannabis sector, including daily videos, weekly chats, model portfolios, a community forum and much more.

Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer a family of indices to track Canadian licensed producers as well as the American Cannabis Operator Index.

View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks that generate industry sales of more than US$12.5M per quarter.

Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.

Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.


Alan & Joel

Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter

Oh Hi Beverages adds high-THC drinks to the mix – The Durango Herald

Judging by its breweries, distilleries, coffee roasters, soda makers and sports supplements, the Durango area clearly has a thing for drinks. And in the cannabis sector, that love manifests itself as Oh Hi Beverages.

The company burst onto the scene in March 2019 with a line of seltzers featuring 10 milligrams of tetrahydrocannabinol, or THC, the psychoactive compound in marijuana. It followed those up with a line of seltzers with cannabidiol, or CBD, another compound derived from cannabis but which does not have a psychoactive effect.

Now, the company is looking to expand its market with a product designed for customers who may have enjoyed its THC seltzers, but are looking for something a bit stronger.

Oh Hi’s new uncarbonated Budtender’s Reserve line ramps the THC up to 100 milligrams – about 10 times the amount in a typical edible – though it’s not necessarily meant to be consumed all at once. Each bottle contains 10 servings of 10 milligrams.

“If you drink the whole thing, you will be really, really, really high. Maybe higher than you want to be,” said John Lynch, director of operations at Oh Hi Beverages.

Oh Hi isn’t the first edible manufacturer to create weed-based drinks with high amounts of THC – a number of sodas and other beverages are available with comparable amounts of the compound. And Oh Hi wants to push into that market, he said.

“We definitely made this product for more the experienced cannabis user. But it’s also great for people who like to make mocktails or non-alcoholic beverages, as a mixer. There are people who are who aren’t looking for the carbonated or the seltzer and want something more than just 10 milligrams. Everyone’s different, so we’re trying to appeal to people with different tolerances,” he said.

A person with a high tolerance for THC would have to drink three or four of Oh Hi’s 10 milligram seltzers to achieve the same result as drinking less than half a bottle of the Budtender’s Reserve.

In December, Oh Hi launched the first two flavors of the line: Tropical Thunder and High Tea. Tropical Thunder is tropical fruit-flavored energy drink, supplementing its 100 milligrams of THC with electrolytes and 140 milligrams of caffeine. High Tea, on the other hand, tastes like iced tea with lemon and is not caffeinated. Lynch said the beverages, which are produced at Durango Organics in Grandview, should reach dispensaries that carry Oh Hi beverages by mid-February and cost about $25 at most locations.

The company plans to roll out three additional flavors in the next couple months: Grateful Grape, Orange Sunshine (with an orange cream flavor) and Sucker Punch (another energy drink, this time with a dark berry punch flavor). None of the beverages use artificial flavors or sweeteners.

Two flavors of Budtender’s Reserve are energy drinks with electrolytes and 140 milligrams of caffeine.

Oh Hi Beverages adds high-THC drinks to the mix

Two flavors of Budtender’s Reserve are energy drinks with electrolytes and 140 milligrams of caffeine.

Lynch said the energy drinks are made with Colorado’s athletic and outdoorsy people in mind.

“It’s a functional beverage that’s great for before you go for a hike or your workout. It’s a good go-get-stuff-done kind of beverage,” he said.

All of Oh Hi’s THC beverages are created with Ripple, a water-soluble cannabinoid powder developed by Stillwater Brands. As a result, the THC can be absorbed sublingually – in the saliva glands – rather than being processed in the stomach and absorbed though the liver like most edibles. This also means that the seltzers’ psychoactive effects can start to within 15 minutes instead of 45 minutes to an hour as is the case with typical edibles.

Oh Hi’s flagship 10 milligram THC seltzers have been well received – the pomegranate flavor won first place in the edible category of High Times’ Cannabis Cup in 2019. And the seltzers are especially popular in the more affluent parts of the state. In addition to Durango, Lynch said they sell well in places like Breckenridge, Denver, Steamboat Springs and Telluride.

He said consumers in some parts of the state shop to maximize the milligrams of THC they get for their dollar, while others simply search for high-quality products. The people who buy Oh Hi’s beverages tend to fall into the latter category.

Sales of the CBD seltzers, which because they contain no psychoactive compounds can be sold in grocery stores in most parts of the country, have been OK but not quite what the company hoped for, Lynch said. Oh Hi is one of the only manufacturers to sell CBD seltzers by the keg, and it saw a lot of on-premise consumption in bars and restaurants that used it to make CBD mocktails and the like. Then the COVID-19 pandemic hit, setting sales back a bit.

He said that ironically, its easier to distribute the THC seltzers throughout the state because dispensaries are actively looking for the product and forming partnerships. Conversely, CBD beverages occupy a gray area – states such as Idaho and Nebraska prohibit CBD, and its legality is unclear in South Dakota – and as a result, the industry is still finding its niche. This is one reason that the company also sells its CBD seltzers directly to customers online.

‘There’s no stopping the industry now’: Democratic control is a big win for marijuana – POLITICO

The company’s payday foreshadows how the entire cannabis industry is poised for growth and consolidation as Democrats take full control of the federal government. Companies are positioning themselves for the greater likelihood that federal cannabis restrictions will be loosened significantly.

Sales are already booming. Cannabis sales hit $20 billion last year — a 50 percent jump over 2019. Legalization continues to spread across the country, with more than one-third of Americans now living in states where marijuana is fully legal.

“There’s no stopping the industry now,” said Andrew Kline, who recently joined the law firm Perkins Coie after serving as public policy director for the National Cannabis Industry Association. “The bigger players are going to be interested in acquiring smaller companies and becoming multi-state operators or expanding their footprint in different states.”

What’s happened so far?

A flurry of deals and capital raises have been made in recent weeks, in addition to Curaleaf cashing in.

Cannabis behemoth Cresco Labs recently bought Bluma Wellness for $213 million, giving it a beachhead in the booming Florida market. There are now more than 450,000 medical marijuana patients in Florida — a more than 50 percent increase in the last year — and 310 dispensaries across the state, nearly 100 more than at the start of 2020.

“I think you’re gonna see a lot of [mergers and acquisitions] coming,” said Bluma Wellness CEO Brady Cobb, who will join Cresco immediately and focus on building its Florida business. “It’s going to be driven by the fact that institutional capital sees light at the end of the tunnel for these companies.”

Cresco also recently announced it will raise $125 million from investors, citing plans to accelerate its growth. The company was already soaring ahead of the political shifts: It had third-quarter revenues of $153 million — more than four times as much as during the comparable period in 2019.

Canadian companies also are eyeing the U.S. market. Cannabis giant Canopy Growth Corp. recently announced a deal — contingent on U.S. legalization — to acquire a big stake in TerrAscend, which has operations in California, Pennsylvania and New Jersey.

The deal is similar to Canopy’s arrangement to buy Acreage Holdings, which has 71 dispensaries and operations in 15 states, if marijuana restrictions in the U.S. are lifted.

Stock prices for some of the biggest cannabis companies have skyrocketed in recent weeks. Acreage’s stock price has nearly doubled since Democrats won control of the Senate, while the price of Cresco’s shares have jumped by more than 30 percent.

“People are scrambling right now, and they’re taking a calculated risk that federal change is going to happen in the near term,” Kline said.

What’s the reality on Capitol Hill?

Despite the ebullient feelings among industry advocates and investors, the likelihood that Congress will make big changes to federal marijuana restrictions remains slim. That’s in large part because Democrats will have a razor-thin majority and need 60 votes to pass most legislation.

That’s why, despite the House’s passage of the MORE Act in the last Congress — which would federally decriminalize cannabis and expunge records — many in the weed industry have their sights set on banking legislation in the new Congress. The SAFE Banking Act — which would make it easier for banks to offer financial services to the cannabis industry — passed the House with broad bipartisan support in 2019, but went nowhere in the GOP-controlled Senate.

With Democrats now in charge of both chambers, industry insiders and policy experts believe banking has a good shot at becoming law — and a much better shot than comprehensive legalization legislation. Even the incoming ranking member on the Senate Banking, Housing and Urban Affairs Committee, GOP Sen. Pat Toomey of Pennsylvania, said he’s open to discussing the issue.

“We’re not going to get full scale legalization from this Senate,” said John Hudak, a cannabis policy expert at The Brookings Institution.

Hudak, however, isn’t surprised by the jump in cannabis stocks following the Georgia runoff.

“There’s a real problem within the business community about an avoidance of working with people who truly understand how federal legislative politics works,” Hudak said. “And there is also a serious problem of lobbyists and others committing political malpractice in selling these businesses a really bad basket of goods.”

Despite the post-election stock market jump and Curaleaf’s own fundraising success, Jordan said he agrees with Hudak’s overall assessment. He doesn’t believe marijuana legalization is likely to pass this Congress, and his business decisions are still motivated more by state policy changes.

“We’re making very large bets,” Jordan said. “Not based on federal legal changes, but based on what we’re seeing the population do at the ballot box.”

No stopping the states

The legalization boom continues to spread across the country. Voters in Arizona, New Jersey, Montana and South Dakota approved ballot measures to legalize, tax and regulate recreational marijuana in November. Altogether, that means 18 million more Americans now live in states where the drug is fully legal.

State legislatures across the country are eyeing legalization too, at least in part because of big budget deficits caused by the pandemic. New York, Virginia, Connecticut and New Mexico are among the states where there will be strong pushes to pass recreational legalization bills in the coming weeks.

Even relatively mature markets saw huge growth in 2020, fueled by anxious Americans stuck in their homes smoking more weed. Sales in Colorado topped $2 billion for the first time, while Oregon saw a 40 percent spike in revenues.

“Companies are doubling [and] tripling in size so that they can keep up with demand,” Trulieve CEO Kim Rivers said. Trulieve is the biggest player in Florida’s medical marijuana market, with a growing footprint around the country. “At the end of the day, there’s still incredible opportunity, even if that doesn’t immediately translate into full federal legalization.”

Primabee hopes to squash uncertainty of CBD products – Cape Cod Times

By Beth Treffeisen
 |  Cape Cod Times

CHATHAM — Walking into Paul Borde’s office is like stepping into a candle store. A smell of lavender wafts through the air as one’s eyes are immediately drawn to the array of CBD products splayed across a large table in the corner. 

Ranging from gummies and oils to salve sticks and hemp extract, the display is enough to spark anyone’s curiosity. 

Two summers ago in 2019, Borde — an avid golfer — suffered from severe lower back pain. After seeing a doctor who suggested surgery, Borde warily asked if there was another way to stop the pain. He was referred to a chiropractor, who introduced him to CBD products. 

At first, Borde said, it sounded like hocus-pocus, but he decided to try it. At the time, he was in so much pain that he struggled to get out of bed every day. Soon after using CBD products, he said, “I became a believer.” 

The blood flow returned to his lower back, and he was able to resume everyday tasks and even golfing. 

When he first retired, Borde didn’t know what he wanted to do next in life. “I was flopping around like a bluefish,” he said. 

After having such a positive experience with CBD products, he decided to open a business selling them. 

He did a big dive into researching the 130 cannabinoids that have been discovered and how they can help people with anxiety, pain and sleep problems. 

By December 2020, Borde and California-based partner Stephen Crane had launched the Primabee online store: 

“We are putting out the best of the best,” Borde said. 

Users find that the products help support daily self-care for calmness, sleep habits, energy management, pain relief, inflammation reduction, skin care, epilepsy seizure reduction and even calming dogs and cats. 

Primabee’s CBD products are legal in all 50 states and do not give users the high or side effects of smoking marijuana.

“We decided to prove our distinct value by putting our customers first, by insisting on product quality transparency,” Crane said in a statement. “We source our hemp from the most ethical U.S.-based farms, and our custom formulators were carefully chosen for creating the purest, properly potent, broad-spectrum CBD products on the market.”

The 2018 Farm Bill removed many of the restrictions on CBD derived from hemp plants. There are many varieties of the cannabis plant, and hemp is the nonintoxicating variety of cannabis. 

Both hemp and marijuana come from the same cannabis species. However, hemp, unlike marijuana, contains less than 0.3% THC, and cannot get someone high. 

In recent years, it seems as if CBD has popped up everywhere, from local pharmacies to being sold in coffee, to even dog kennels as a way to soothe pets’ anxieties. 

Many of those products, however, are not of high quality. And some, Borde said, don’t even have CBD in them. 

Borde said he believes many of the products recently approved by the federal government were rushed to market with little regulation. 

“It’s a battle back and forth and people are taking advantage,” he said. 

To combat that, Borde said, he hopes Primabee can educate people about what CBD is and how it can help them. He also wants his business to provide “the best-in-class ingredients” and use top-notch manufacturing to give consumers the best products possible. 

For now, due to the COVID-19 pandemic, opening a brick-and-mortar store is not a top priority for the business, Borde said. The goal is to build out the online store while working with local businesses here on Cape Cod. 

Over the holiday season, the company partnered with Cape Cod Lavender Farms to offer customers gift packages that included a sachet of fresh lavender, bath bombs infused with CBD and a candle. 

If someone asks why they should start using CBD products, Borde said he would point to his own experience. 

“It has helped me with sleep, migraines and anxiety,” he said, adding that when his friend places the salve on his shoulder for pain, it is an “instant reaction.” 

5 Ways To Quickly Gauge If Your CBD Product Is Working –

CBD is one of over 100 cannabinoids present in a hemp extract. Once consumed, these cannabinoids interact mainly with the body’s endocannabinoid system (ECS). Essentially, they help this system do its job of maintaining balance throughout the body.*

Also known as our master regulatory system, the ECS has a hand in a number of processes—including the inflammation response.* There’s also some research to show that similar cannabinoids to those found in hemp are released during exercise, explaining that calm, content „runner’s high” feeling throughout the body.* (Indeed, some people have noticed that taking a hemp extract makes them feel like they just went on a jog.)

Moral of the story: By promoting activity in the ECS, hemp extract seems to help ease chronic pain in adults and contribute to an all-around relaxed sensation throughout the body.*

Ambient Vaporizer Market Size, Status, Progress Outlook 2020-2025 – The Courier – The Courier

The Ambient Vaporizer Market Research Report 2020-2025, offers an in-depth evaluation of each crucial aspect of the Global Ambient Vaporizer industry that relates to market size, share, revenue, demand, sales volume, and development in the market. The report analyzes the Ambient Vaporizer market over the values, historical pricing structure, and volume trends that make it easy to predict growth momentum and precisely estimate forthcoming opportunities in the Ambient Vaporizer Market. The report explores the current outlook in global and key regions (North America, Europe, Asia-Pacific, and Latin America) from the perspective of players, countries (U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc.), product types, and end industries.

To Remain ‘In front of’ Your Competitors, Request For Sample Report Here (Use Corporate email ID to Get Higher Priority): (FLAT 20% OFF)

Global Major Players in Ambient Vaporizer Market are:
Linde Engineering, Sing Swee Bee Enterprise, Cryolor, Cryoquip, Cryonorm, Triumph, Fiba Technologies, Fuping Gas Equipment, Isisan Isi, Chart Industries, Inox India, and Other.

Most important types of Ambient Vaporizer covered in this report are:
Low Pressure Ambient Vaporizer

High Pressure Ambient Vaporizer

Most widely used downstream fields of Ambient Vaporizer market covered in this report are:
Industrial Gas


Petrochemical Industries

Influence of the Ambient Vaporizer Market report:
–Comprehensive assessment of all opportunities and risks in the Ambient Vaporizer Market.
–Ambient Vaporizer Market recent innovations and major events.
–A detailed study of business strategies for the growth of the Ambient Vaporizer Market market-leading players.
–Conclusive study about the growth plot of Ambient Vaporizer Market for forthcoming years.
–In-depth understanding of Ambient Vaporizer Market, market-particular drivers, constraints, and major micro markets.
–Favorable impression inside vital technological and market latest trends striking the Ambient Vaporizer Market.

Browse Full Report Here:

What are the market factors that are explained in the report?

-Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

-Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

-Analytical Tools: The Global Ambient Vaporizer Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

The research includes historic data from 2015 to 2020 and forecasts until 2025 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

We also offer customization on reports based on specific client requirement:

1- Free country level analysis for any 5 countries of your choice.

2- Free Competitive analysis of any market players.

3- Free 40 analyst hours to cover any other data points.

About Us:
Market Intelligence Data
provides syndicated market research on industry verticals including Healthcare, Information, and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc., Market Intelligence Data provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:
Irfan Tamboli (Head of Sales) | Market Intelligence Data

Phone: +1 (704) 266-3234

Global COVID-19 IMPACT ON E-CIGARETTES AND VAPORIZER Market Size, Share, Value, and Competitive Landscape 2020-2026 – NeighborWebSJ – NeighborWebSJ

Covid-19 Impact on E-Cigarettes and Vaporizer Market Global Research Report by Product Type (Disposable E-Cigarette, Rechargeable E-Cigarette, Ego and Tanks, Personal Vaporizers and Mods and others) and Region

Market Analysis

Global Covid-19 Impact on E-Cigarettes and Vaporizer Market is majorly driven by the factors such as the presence of established brands, cost-effectiveness, perceived health benefits, and product customizations. Globally, the consumption of tobacco has become a critical issue despite of several government initiatives to increase the awareness about the health issues caused by consuming tobacco. Consumers addicted to tobacco find it difficult to get rid of the addiction and would require an alternate to tobacco. This has turned out to be one of the major drivers for the growth of the E-Cigarettes and vaporizer market globally. Alarming health issues caused due to the addiction of tobacco is the main driver to promote growth in the market. Growing number of cancer patients due to excessive consumption of tobacco worldwide is one of the major reasons that prompted the addicts to get rid of it. However, several people find it difficult to succeed to do so and hence prefer e-cigarette over conventional cigarettes this in turn has resulted in to people switching from conventional cigarettes to e-cigarettes over the past couple of years.

 Also Read:

Although there are no major side effects known, a very few of customers have reported with the allergic symptoms to PG which simply causes some irritation in the throat. All known side effects are typically associated with cigarette withdraw and not with E-Cigarettes & Vaporizer devices. These negligible side effects coupled with factors such as, increasing incidents of e-liquid poisoning, uncertain regulatory framework and the high costs associated with these devices may hamper the market growth during the projected period.

Also Read:


Leading Key Players Update

Companies are in the process of capturing & solidifying their share of the Covid-19 Impact on E-Cigarettes and Vaporizer Market segment, by competing and experimenting with various advantage points. The entry of new industry players in the segment has initiated a trend of volume-driven growth that has been observed to intensify with the addition of new and advanced products. The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in the optimal strategies.

Few of the major players in Global Covid-19 Impact on E-Cigarettes and Vaporizer Market include Dash Vapes, Hubbly Bubbly, Liquideu, Uff Ecig, Simple Vape Co., Nice Vapor and Pacific Smoke International. Growing awareness about ill-effects of tobacco together with consumers’ rising preference for e-cigarette over conventional cigarettes to quit tobacco has driven the market in North America and Europe over the past few years.

 Also Read:


Industry Segments

Global Covid-19 Impact on E-Cigarettes and Vaporizer Market is segmented in to 2 dynamics for the convenience of the report and enhanced understanding.

Segmentation By Product Type: Comprises Disposable E-Cigarette, EGO and Tanks, Rechargeable E-Cigarette, Personal Vaporizers and Mods and Others.

Segmentation by Regions: Comprises Geographical regions – Europe, North America, APAC and Rest of the World.

Disposable e-cigarettes have accounted for the largest market size by product type in 2015 accounting for nearly 30% of the market size closely followed by rechargeable e-cigarette.

Personal vaporizers will grow at a CAGR over 23.5% through the forecast period

Also Read:


Regional Analysis

Currently, North America is the largest consumer of E-Cigarettes & Vaporizer in the world market. It is closely followed by Europe. Although, China began as the first market for E-Cigarettes & Vaporizer, the U.S. and developed markets from Europe became the prime consumers of E-Cigarettes & Vaporizer, due to which these two regions collectively account for over 80% of the world market. APAC will be growing at the fastest CAGR, accounting for more than 20% of the global e-cigarette market value by 2021. Significant revenue flow will be observed from China and India over the forecast period.



About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Contact Us:


[email protected]

Ph: +162-825-80070 (US)

Ph: +44 2035002763 (UK)

State cannabis office announces dispensary permit recipients, start of patient registration – West Virginia MetroNews

CHARLESTON, W.Va. — The West Virginia Office of Medical Cannabis has announced the recipients of permits to operate medical cannabis dispensaries.

Recipients can operate retail locations within the state:

— Harvest Care Medical LLC with locations in Inwood, Kearneysville, Martinsburg, Huntington, Charles Town, Shepherdstown, Charleston, St. Albans and Fairmont.
— Yuma Way WV LLC with a location in Huntington.
— Holistic WV Farms LLC with locations in Barboursville, Martinsburg, Bridgeport, Charleston, South Charleston, logan, Bluefield, Star City, Elkins and Parkersburg.
— Organic Remedies WV Inc. in Morgantown
— Terrasana with retail locations in Beckley, Charleston, Fayetteville, Huntington, Morgantown and Princeton.
— Verano WV LLC with locations in Oak Hill, Clarksburg, Dunbar, Morgantown, Westover, Wheeling and Buckhannon.
— Curative Growth Inc. with businesses in Springfield, Fairmont and Morgantown.
— Marachem Inc. in Barboursville.
— Mountaineer Holding LLC with locations in Belle and Vienna.
— Mountaineer Integrated Care in Ravenswood.
— The Healing Center WV LLC in Weirton, Fairmont, Westover, Triadelphia and Parkersburg.
— V3 WV Vending LLC with locations in Martinsburg, Lewisburg, Bridgeport, Jefferson and Beckley.
— Capital City Health and Wellness LLC in Charleston.
— The Next Level Wellness #1 Inc. in Clarksburg, Weston and Kingwood.
— Columbia Care WV with spots in Fayetteville, St. Albans, Morgantown, Beckley and Williamstown.
— Mountaineer Remedy LLC in Parkersburg.
— Green Leaf Medical of West Virginia LLC in Charleston.
— Greenhouse Wellness WV Dispensaries LLC in Martinsburg.
— WV Kindness LLC in Huntington.
— Armory Pharmaceutical, Inc. in Buckhannon.
— Logan Investment Partners LLC with locations in Lewisburg, Mt. Gay and Stollings.
— New Leaf WV LLC with businesses in Martinsburg, Kearneysville, Morgantown and Berkeley Springs.
— Tariff Labs in Clendenin and Spencer.
— Trulieve WV Inc. with locations in South Charleston, Weston, Morgantown and Buckhannon.
— CAMO Medical West Virginia LLC in Huntington.
— Compiler Wellness LLC with businesses in Barboursville, Huntington and Charleston.
— Compiler Wellness LLC with locations in Huntington and Charleston.
— WVLINE LLC in Charles Town.
— Mountaineer Releaf LLC with locations in Huntington, Weirton, Ravenswood, Morgantown and Beckley.
— Capital Mountain LLC with locations in Clarksburg, Ranson and Elkins.
— CPKH 2 LLC in Parkersburg.
— Solevo Wellness West Virginia with locations in Morgantown and Parkersburg.
— ECS Partners LLC in Weirton.

Eligible West Virginians will be able to start applying Wednesday to receive medical cannabis. People with serious medical conditions will receive a patient card.

Registration will open Feb. 3 at noon. Interested people can fill out the related information form at

“ven during this pandemic, the Office of Medical Cannabis has been working hard to advance the program and to achieve these steps to ensure that medical cannabis is made available to West Virginia residents with serious medical condition,” office Director Jason Frame said Friday in a release.